CMPI
Checkmate Pharmaceuticals, Inc. Common Stock
CMPI
CMPI
Delisted
CMPI was delisted on the 27th of May, 2022.
36 hedge funds and large institutions have $236M invested in Checkmate Pharmaceuticals, Inc. Common Stock in 2020 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 13 increasing their positions, 8 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
Holders
36
Holding in Top 10
4
Calls
–
Puts
–
Top Buyers
| 1 | +$959K | |
| 2 | +$286K | |
| 3 | +$278K | |
| 4 |
Bank of New York Mellon
New York
|
+$254K |
| 5 |
JP Morgan Chase
New York
|
+$164K |
Top Sellers
| 1 | -$757K | |
| 2 | -$715K | |
| 3 | -$706K | |
| 4 |
CCM
CAAS Capital Management
New York
|
-$518K |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$336K |